Skip to main content

Peer Review reports

From: Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers

Original Submission
1 Jun 2017 Submitted Original manuscript
7 Aug 2017 Reviewed Reviewer Report - Jin-Yuan Shih
14 Sep 2017 Reviewed Reviewer Report - Tianhong Li
13 Oct 2017 Author responded Author comments - Yan Wang
Resubmission - Version 2
13 Oct 2017 Submitted Manuscript version 2
12 Dec 2017 Reviewed Reviewer Report - Jin-Yuan Shih
2 Jan 2018 Reviewed Reviewer Report - Tianhong Li
8 Feb 2018 Author responded Author comments - Yan Wang
Resubmission - Version 3
8 Feb 2018 Submitted Manuscript version 3
Publishing
21 Mar 2018 Editorially accepted
27 Mar 2018 Article published 10.1186/s12885-018-4277-x

You can find further information about peer review here.

Back to article page